Naltrexone And Bupropion
Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)
Orexigen Therapeutics, Inc · Phase 2/3 · Completed · Enrollment 92
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Behavioral Weight Loss (BWL) + Naltrexone and Bupropion (NB) medication | 7 participants | 2 participants | 3 participants | n/r | 0 |
| BWL + Placebo | 0 participants | 0 participants | 3 participants | n/r | 0 |
| NB medication | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.